Relationship between polymorphism of NH-κB1 and NF-κB1α and susceptibility to hepatitis B virus-associated hepatocellular carcinoma: A case-control study

Academic Journal of Second Military Medical University

Volumn 30, Issue 4, 2009, Pages 349-354

  He, Yong Chao ^a   Yin, Jian Bua ^a   Xie, Jia Xin ^a   Zhang, Hong Wei ^b   Liu, Shi Jian ^a   Chang, Wen Jun ^a   Li, Cheng Zhong ^b   Zhang, Qian ^b   MA, Li Ye ^b   Cao, Guang Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Case control studies; Genetic polymorhpism; Hepatocellular carcinoma; NF B1; NF B1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING; VIRUS CARCINOGENESIS;

EID: 65449123096     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2010.00349     Document Type: Article

References (17)

1. Chinese source.
2. Chinese source.
3. Qian G S, Ross R K, Yu M C, Yuan J M, Gan Y T, Henderson B E, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China[J]. Cancer Epidemiol Biomarkers Prev, 1994,3:3-10.
4. Edenberg H J, Xuei X, Wetherill L F, Bierut L, Bucholz K, Dick D M, et al. Association of NFκBl, which encodes a subunit of the tran scription factor NF-kappaB, with alcohol dependence[J]. Hum Mol Genet, 2008,17:963-970.
5. Buendia M A. Genetics of hepatocellular carcinoma[J]. Semin Cancer Biol, 2000,10:185-200.
6. Shastry B S. SNP alleles in human disease and evolution[J]. J Hum Genet, 2002,47:561-566.
7. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences [J]. Cell, 1986,46:705-716.
8. Shin S R, Sánchez Velar N, Sherr D H, Sonenshein G E. 7,12-dimethylbenz(a) anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB[J]. Cancer Res, 2006, 66: 2570-2575.
9. Spink C F, Gray L C, Davies F E, Morgan G J, Bidwell J L. Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma[J]. Cancer Lett, 2007, 246 (1-2): 92-99.
10. Curran J E, Weinstein S R, Griffiths L R. Polymorphic variants of NFκBl and its inhibitory protein NFκBIA, and their involvement in sporadic breast cancer[J]. Cancer Lett, 2002,188(1-2):103-107.
11. Kim L H, Shin H D, Park B L, Jung J H, Kim J Y, Kim Y J, et al. Identification of variants in NFΚBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients[J]. Hum Mutat, 2003,21: 652-653.
12. Arsura M, Cavin L G. Nuclear factor-kappaB and liver carcinogenesis [J]. Cancer Lett, 2005,229:157-169.
13. Edenberg H J, Xuei X, Wetherill L F, Bierut L, Bucholz K, Dick D M, et al. Association of NFκBl, which encodes a subunit of the transcription factor NF kappaB, with alcohol dependence[J]. Hum Mol Genet, 2008,17:963-970.
14. Lin S, Wu M, Xu Y, Xiong W, Yi Z, Zhang X, et al. Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation [J]. Biochim Biophys Acta, 2007, 1772: 1150-1157.
15. Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area[J]. Carcinogenesis, 2008, 29: 1685-1691.
16. Yin J H, He Y C, Li C Z, Zhou Y, Zhang H W, Cao G W. Distribution of HBV genotypes and subgenotypes in patients with chronic hepatitis B, hepatocellular carcinoma, asymptomatic HNV carriers and its clinical relevance [J]. Acad J Sec Mil Med Univ, 2008, 29:1-5.
17. Yin J H, Zhou Y, He Y C, Zhang H W, Cao G W. Role of HBV subgenotype C2, B2 in carcinogenesis, treatment and prognosis of hepatocellular carcinoma[J]. Acad J Sec Mil Med Univ, 2008, 29: 162-166.